Clinical Trials · NCT02156960

Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

Name: Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 4Teriparatide

Phase: Phase 4
Recruitment status: Unknown
Sponsor: Shinshu University
Enrollment: 100
Start date: May 2014
Locations: 1 site, Japan
Primary endpoint: Changes of bone mineral density

View Teriparatide compound reference